Kunhua Li

Kunhua Li is currently working as a Principal Scientist at Kymera Therapeutics since May 2023. Previously, they held the position of Senior Scientist at FogPharma from January 2022 to May 2023 and Scientist II from November 2019 to December 2021. Before that, they worked as a Postdoctoral Fellow at Harvard Medical School from July 2016 to November 2019 and and as a Research Fellow at the Dana-Farber Cancer Institute from June 2016 to November 2019. Their earlier experience includes serving as a Research Assistant at the University of Florida from February 2011 to May 2016.

Kunhua Li earned a Bachelor's degree in Chemistry from Peking University in 2010. From 2010 to 2016, they pursued a Doctor of Philosophy (Ph.D.) in Chemistry and Biochemistry at the University of Florida. Additionally, from 2012 to 2014, they obtained a Master of Science in Teaching (Education) from the University of Florida.